Johnson Johnson Innovation Launches Digital Beauty QuickFire Challenge to Tackle some of the Toughest Consumer Skincare Problems

Food and Healthcare Press Releases Tuesday November 14, 2017 16:03
SAN FRANCISCO--14 Nov--PRNewswire/InfoQuest

Johnson & Johnson Innovation LLC, in collaboration with Johnson & Johnson Consumer Inc., today announced the launch of the Digital Beauty QuickFire Challenge. The challenge will encourage start-up companies to create the most novel, future-forward digital beauty solutions in an effort to provide better skincare outcomes for consumers around the world. The winner(s) of the challenge will receive up to a total of $50,000 in funding to help advance their product prototype toward commercialization. In addition to funding, Johnson & Johnson Innovation will also provide the winner(s) with access to a network of experts, residency for up to one year at an available Johnson & Johnson Innovation, JLABS (JLABS), and admission to a Johnson & Johnson Consumer Experience Center (CxC). At the CxC, the winner(s) will be able to custom design and execute one free research initiative.

Logo - http://mma.prnewswire.com/media/602394/Johnson_Johnson_Innovation_Logo.jpg

"True innovation doesn't just elevate product experiences and outcomes—it challenges the very definition of skin care itself," said Sebastien Guillon, President, Global Beauty, Johnson & Johnson Consumer Inc. "The next beauty tech disrupters are out there, and this Challenge will help us identify the most promising potential partners in the co-creation of meaningful, future-forward skin solutions."

The QuickFire Challenge, an initiative from JLABS—the no strings attached incubators—seeks to empower and enable groundbreaking science and health solutions by encouraging students, entrepreneurs, researchers, and start-up companies to apply. The Digital Beauty QuickFire Challenge will focus on three innovation areas:

1. Insights-Generating Tools that empower consumers to make better informed skincare choices, such as at-home skin assessments, coaching engines, and personalization tools to simplify product selection and build regimen.

2. Impact Tracking Devices and Adherence Solutions that help improve consumers' skin health management by monitoring skin-impacting factors such as pollution, UV, and skin biomarkers.
3. Digital Technologies or Devices that increase efficacy beyond traditional topical applications to progress skin health for consumers with hard to treat concerns such as acne, photoaging, and eczema.

"To achieve this, we are seeking innovative devices and digital technology solutions to make the invisible visible and tackle the toughest skincare challenges," said Naomi Furgiuele, Vice President, Global Face and Sun R&D, Johnson & Johnson Consumer Inc. "By creating powerful connected experiences with those outside of our company walls, we are able to build consumer preference, loyalty, and unique personalization."

Information about entering the challenge and entry guidelines can be found online at https://jlabs.tv/DigitalBeauty . The deadline to submit an application is January 19, 2018. Qualifying entries will be evaluated and the winner(s) will be selected and announced in Spring 2018.

About Johnson & Johnson Innovation

Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, JLABS, Johnson & Johnson Innovation - JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit www.jnjinnovation.com .

About Johnson & Johnson Innovation, JLABS

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors. For more information about JLABS, please visit www.jlabs.jnjinnovation.com .

About Johnson & Johnson Consumer Inc.

Johnson & Johnson Consumer Inc. is one of the world's largest consumer health and personal care product companies. With its global headquarters located in New Brunswick, NJ, Johnson & Johnson Consumer Inc. produces many of the world's most trusted brands: JOHNSON'S(R), BAND-AID(R) Brand Adhesive Bandages, NEUTROGENA(R), TYLENOL(R), MOTRIN(R), and LISTERINE(R). Johnson & Johnson Consumer Inc. embraces innovative science to create products that anticipate consumer needs, while also creating experiences that help consumers live healthy, vibrant lives. For more information about Johnson & Johnson Consumer Inc., please visit https://www.jnj.com/healthcare-products/consumer .


Latest Press Release

Covaris Introduces the 96 oneTUBE-10 AFA Plate for Improved NGS Workflows

Today, Covaris Inc. announced the release of the 96 oneTUBE-10 AFA Plate, which enables scalable and simplified workflows by leveraging Covaris' gold standard focused-acoustic technology to meet rapidly increasing Next-Generation Sequencing (NGS) demands...

2018 Empire State Building Run-Up Lottery Registration Opens on November 14, 2017

Runners must enter by December 10 for a chance to participate in the 41st Annual Run-Up on Wednesday, February 7, 2018, at 8:00 p.m. Empire State Realty Trust, Inc. (NYSE: ESRT) today announced that lottery registration for the 2018 Empire State...

Alpinion Medical Systems Launches E-CUBE 8, the New Ultrasound Diagnostic System

One of South Korea's global medical device manufacturers, Alpinion Medical Systems introduced its new E-CUBE 8, the latest and last addition to the E-CUBE lineup. The E-CUBE 8 is a smart, reliable product that ensures high performance with outstanding...

Photo Release: The Royal Danish Embassy and Novo Nordisk Pharma (Thailand) Co., Ltd launch the Blueprint for Change address Diabetes challenge , aligned with national NCD targets

On the 5th November 2017, right after the WDD event at the Vachirabenjatas Park (Suan Rot Fai Park) . Mr.Uffe Wolffhechel, the ambassador of the Royal Danish Embassy, Thailand (right) together with Mr.Mihai Irimescu, General Manager of Novo Nordisk...

Stryker announces publication of the DAWN(TM) Trial results in the New England Journal of Medicine

The New England Journal of Medicine published the results of the DAWN Trial, the first to provide compelling evidence in treating late window and wake-up stroke patients with mechanical thrombectomy. Currently, less than one in 10 patients suffering from...

Related Topics